DISC MEDICINE INC

IRONNASDAQ

🏆 #1847 by market capEarnings Nov 4US Equity

$776.25▼ $26.08 (−3.36%)

Simulated price

🔔

Track IRON

Get earnings, price moves & breaking news on Telegram

Track

24h▼ 3.4%

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

$2.49B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

No chart data available for IRON.

Trading Snapshot

Day Range: $766.77 – $783.60
52-Week Range: $40.00 – $99.50
Volume: $2.06B
Avg Volume: $2.59B
Shares Outstanding: 38.2M
Next Earnings: Nov 25, 2026

Fundamentals Snapshot

Annual Revenue: $158M
Last Q Revenue: $43M
P/E Ratio: —
P/S Ratio: —
EPS (TTM): $-6.57
Dividend Yield: —
Dilution (1yr): +17.9%

Why Investors Own IRON

✓High-growth profile — revenue up +3.3% YoY with expanding US Equity exposure.
✓Healthy economics — 61% gross margin and 8% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

DISC MEDICINE INC

IRON

Financial Trends

Revenue

$0▲ +0.0% YoY

Operating Income

−$236M▲ +81.9% YoY

Free Cash Flow

−$181M▲ +92.0% YoY

Shares Outstanding

35.3M▲ +17.9% YoY

Net Cash

$89M▼ −$73M YoY

StockOtter · stockotter.space

About DISC MEDICINE INC

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

🦦